These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2945071

  • 1. The effect of large doses of ethinylestradiol on apolipoprotein levels in excessively tall prepubertal girls.
    Leuven JA, van Stiphout WA, van Gelderen HH, Reeser HM, Havekes L, Hofman A.
    Metabolism; 1986 Oct; 35(10):978-80. PubMed ID: 2945071
    [Abstract] [Full Text] [Related]

  • 2. Impact of different doses of ethinyl oestradiol on reduction of final height in constitutionally tall girls.
    Joss EE, Zeuner J, Zurbrügg RP, Mullis PE.
    Eur J Pediatr; 1994 Nov; 153(11):797-801. PubMed ID: 7843192
    [Abstract] [Full Text] [Related]

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Nov; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 4. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Nov; 21(3):143-6. PubMed ID: 2149913
    [Abstract] [Full Text] [Related]

  • 5. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R.
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [Abstract] [Full Text] [Related]

  • 6. Effect of large-dose progesterone on plasma levels of lipids, lipoproteins and apolipoproteins in males.
    Chen JJ, Berlin FS, Margolis S.
    J Endocrinol Invest; 1986 Aug; 9(4):281-5. PubMed ID: 2946755
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
    Voorhoof L, Rosseneu M, Caster H, De Keersgieter W.
    J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
    [Abstract] [Full Text] [Related]

  • 8. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L, Landgren BM, Lindberg UB, Silfverstolpe G, Crona N.
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [Abstract] [Full Text] [Related]

  • 9. Bone age progression during five years of substitutive therapy for the induction of puberty in thalassemic girls--effects on height and sitting height.
    Filosa A, Di Maio S, Lamba M, Baron I, Saviano A, Esposito G.
    J Pediatr Endocrinol Metab; 1999 Feb; 12(4):525-30. PubMed ID: 10417968
    [Abstract] [Full Text] [Related]

  • 10. Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol.
    Normann EK, Trygstad O, Larsen S, Dahl-Jørgensen K.
    Arch Dis Child; 1991 Nov; 66(11):1275-8. PubMed ID: 1755636
    [Abstract] [Full Text] [Related]

  • 11. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
    Telimaa S, Penttilä I, Puolakka J, Rönnberg L, Kauppila A.
    Fertil Steril; 1989 Jul; 52(1):31-5. PubMed ID: 2526031
    [Abstract] [Full Text] [Related]

  • 12. Effect of different oestrogen doses on final height reduction in girls with constitutional tall stature.
    Grüters A, Heidemann P, Schlüter H, Stubbe P, Weber B, Helge H.
    Eur J Pediatr; 1989 Oct; 149(1):11-3. PubMed ID: 2606121
    [Abstract] [Full Text] [Related]

  • 13. No effect of ethinylestradiol treatment on melatonin secretion in healthy pubertal girls.
    Commentz J, Willig R.
    Exp Clin Endocrinol Diabetes; 1995 Oct; 103(1):52-7. PubMed ID: 7621105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC, Alaupovic P, Cox DW, Little JA.
    Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
    [Abstract] [Full Text] [Related]

  • 16. High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives-differences between two frequently used low-estrogen pills.
    Havekes L, van Gent CM, Stegerhoek CI, Arntzenius AC, Hessel LW.
    Clin Chim Acta; 1981 Oct 26; 116(2):223-9. PubMed ID: 6457706
    [Abstract] [Full Text] [Related]

  • 17. [Growth inhibition using estrogens in constitutionally tall girls].
    Du Caju MV, Bleyaert S, Op De Beeck L.
    Acta Clin Belg; 1993 Oct 26; 48(1):11-9. PubMed ID: 8388600
    [Abstract] [Full Text] [Related]

  • 18. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Oct 26; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 19. Increase of serum prolactin during combined high-dose estrogen and progestin treatment in girls with constitutional tall stature.
    Houdijk EC, Delemarre-van de Waal HA.
    Acta Paediatr; 2000 Dec 26; 89(12):1504-5. PubMed ID: 11195249
    [No Abstract] [Full Text] [Related]

  • 20. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.